PhD Studentship - Genetic and Therapeutic Determinants of Adverse Drug Reactions in Cardio-Renal Diseases
This interdisciplinary PhD project investigates how genetic variation, prescribing, and patient characteristics influence treatment response and drug safety in cardiometabolic diseases. You will analyze large genomic and clinical datasets, focusing on cutting-edge therapies like SGLT2 inhibitors and DOACs, to inform precision medicine and NHS clinical guidance.